IngentaConnect Search Results

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study

Authors: Kipnes, Mark S.; Roth, Eli M.; Rhyne, James M.; Setze, Carolyn M.; Lele, Aditya; Kelly, Maureen T.; Sleep, Darryl J.; Stolzenbach, James C.

Source: Clinical Drug Investigation, Volume 30, Number 1, 1 January 2010 , pp. 51-61(11)

Publisher: Adis International

Association of polycystic ovary syndrome with cardiovascular risk factors

Authors: Akram, Tanzeela; Hasan, Shahid; Imran, Muhammad; Karim, Asima; Arslan, Muhammad

Source: Gynecological Endocrinology, Volume 26, Number 1, January 2010 , pp. 47-53(7)

Publisher: Informa Healthcare

Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population

Authors: Li, Nan F.; Wang, Hong M.; Yang, Jin; Zhou, Ling; Yao, Xiao G.; Hong, Jing

Source: Applied Physiology, Nutrition, and Metabolism, Volume 34, Number 6, 1 December 2009 , pp. 1032-1039(8)

Publisher: NRC Research Press

Risk Factors for Retinal Arteriolar Emboli in Coronary Artery Disease

Authors: Alp, B.N.; Bozbuğa, N.; Alp, M.

Source: The Journal of International Medical Research, Volume 37, Number 5, September 2009 , pp. 1301-1310(10)

Publisher: Field House Publishing

Fenofibric Acid: In Combination Therapy in the Treatment of Mixed Dyslipidemia

Authors: Yang, Lily P.H.; Keating, Gillian M.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 6, 1 December 2009 , pp. 401-409(9)

Publisher: Adis International

Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome

Authors: Hu, Peng; Lu, Ling; Hu, Bo; Du, Peng Fei

Source: Scandinavian Journal of Clinical and Laboratory Investigation, Volume 69, Number 6, October 2009 , pp. 680-686(7)

Publisher: Informa Healthcare

Dyslipidemia as a Risk Factor for Ischemic Stroke

Authors: Tziomalos, Konstantinos; Athyros, Vasilios G.; Karagiannis, Asterios; Mikhailidis, Dimitri P.

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 14, October 2009 , pp. 1291-1297(7)

Publisher: Bentham Science Publishers

Association between serum adipocytokine and cholesterol levels in cord blood

Authors: Nakano, Yuya; Itabashi, Kazuo; Maruyama, Takeshi

Source: Pediatrics International, Volume 51, Number 6, December 2009 , pp. 790-794(5)

Publisher: Blackwell Publishing

Dyslipidemia and cardiovascular risk: the importance of early prevention

Author: Miller, M.

Source: QJM: An International Journal of Medicine, Volume 102, Number 9, 18 September 2009 , pp. 657-667(11)

Publisher: Oxford University Press

A genome-wide scan for quantitative trait loci affecting serum glucose and lipids in a White Duroc × Erhualian intercross F₂ population

Authors: Chen, Rongrong; Ren, Jun; Li, Wanbo; Huang, Xiang; Yan, Xueming; Yang, Bin; Zhao, Yinggong; Guo, Yuanmei; Mao, Huirong; Huang, Lusheng

Source: Mammalian Genome, Volume 20, Number 6, June 2009 , pp. 386-392(7)

Publisher: Springer

Amlodipine/Atorvastatin Single-Pill Therapy for Blood Pressure and Lipid Goals in African Americans: Influence of the Metabolic Syndrome and Type 2 Diabetes Mellitus

Authors: Ferdinand, Keith C.; Flack, John M.; Saunders, Elijah; Victor, Ronald; Watson, Karol; Kursun, Attila; Jamieson, Michael J.; Shi, Harry

Source: The Journal of Clinical Hypertension, Volume 11, Number 10, October 2009 , pp. 585-593(9)

Publisher: Blackwell Publishing

Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

Authors: Ose, Leiv; Budinski, Dragos; Hounslow, Neil; Arneson, Valerie

Source: Current Medical Research and Opinion, Volume 25, Number 11, November 2009 , pp. 2755-2764(10)

Publisher: Informa Healthcare

The good and the bad: what researchers have learned about dietary cholesterol, lipid management and cardiovascular disease risk since the Harvard Egg Study

Author: Constance, C.

Source: International Journal of Clinical Practice, Volume 63, Supplement 163, October 2009 , pp. 9-14(6)

Publisher: Blackwell Publishing

Novel Lipids Targets in the Era of Metabolic Syndrome: Toward a Better Prediction of Cardiovascular Risk

Authors: Paneni, Francesco; Palano, Francesca; Testa, Marco

Source: High Blood Pressure & Cardiovascular Prevention, Volume 16, Number 3, 1 September 2009 , pp. 93-100(8)

Publisher: Adis International

Clinical experience with ezetimibe/simvastatin in a Mediterranean population

Authors: Migdalis, I.; Efthimiadis, A.; Pappas, St.; Alexopoulos, D.; Vlasserou, F.; Mikhailidis, D. P.

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2571-2576(6)

Publisher: Informa Healthcare

Gene-Activators Prevent and Regress Atherosclerosis and Reduce Mortality

Author: Luoma, Pauli V.

Source: Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Volume 7, Number 4, October 2009 , pp. 295-304(10)

Publisher: Bentham Science Publishers

Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny

Authors: de Moura, Egberto Gaspar; Bonomo, Isabela Teixeira; Nogueira-Neto, José Firmino; de Oliveira, Elaine; Trevenzoli, Isis Hara; Reis, Adelina Martha; Passos, Magna Cottini Fonseca; Lisboa, Patricia Cristina

Source: The Journal of Physiology, Volume 587, Number 20, October 2009 , pp. 4919-4929(11)

Publisher: Blackwell Publishing

High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis

Authors: Carvalho, Jozélio; Bonfá, Eloísa; Bezerra, Mailze; Pereira, Rosa

Source: Clinical Rheumatology, Volume 28, Number 7, July 2009 , pp. 801-805(5)

Publisher: Springer

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

Authors: Kerekes, György; Soltész, Pál; Dér, Henriett; Veres, Katalin; Szabó, Zoltán; Végvári, Anikó; Szegedi, Gyula; Shoenfeld, Yehuda; Szekanecz, Zoltán

Source: Clinical Rheumatology, Volume 28, Number 6, June 2009 , pp. 705-710(6)

Publisher: Springer

Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs—apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes

Authors: Niemi, Jaakko; Makinen, Ville-Petteri; Heikkonen, Jukka; Tenkanen, Leena; Hiltunen, Yrjo; Hannuksela, Minna; Jauhiainen, Matti; Forsblom, Carol; Taskinen, Marja-Riitta; Kesaniemi, Y. Antero; Savolainen, Markku; Kaski, Kimmo; Groop, Per-Henrik; Kovanen, Petri; Ala-Korpela, Mika

Source: Annals of Medicine, Volume 41, Number 6, 2009 , pp. 451-461(11)

Publisher: Informa Healthcare